Trial
NCT06965309
Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shenzhen MagicRNA Biotechnology Co., Ltd
Collaborators
Shanghai General Hospital (Songjiang Branch)
Condition
Refractory Myasthenia Gravis
Intervention
HN2301 injection
Why stopped
Change of registrant
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-12